$BANL
CBL International Ltd Stock $banl

$banl Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 20-F Financial Statement

#000149315224015142 Filed on April 18, 2024

Income Statement

Concept	2023 Q4	2023	2022
Revenue	$435.9M	$435.9M	$462.9M
YoY Change	-5.83%	-5.83%	41.76%
Cost Of Revenue	$428.7M	$428.7M	$453.8M
YoY Change	-5.53%	-5.53%	42.27%
Gross Profit	$7.211M	$7.211M	$9.125M
YoY Change	-20.97%	-20.97%	20.21%
Gross Profit Margin	1.65%	1.65%	1.97%
Selling, General & Admin	$5.549M	$5.549M	$4.365M
YoY Change	27.14%	27.14%	29.92%
% of Gross Profit	76.95%	76.95%	47.83%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$90.83K	$142.9K	$94.87K
YoY Change	98.32%	50.62%	-22.72%
% of Gross Profit	1.26%	1.98%	1.04%
Operating Expenses	$5.549M	$5.549M	$4.365M
YoY Change	27.14%	27.14%	29.92%
Operating Profit	$1.662M	$1.662M	$4.760M
YoY Change	-65.09%	-65.09%	12.51%
Interest Expense	-$230.0K	$231.6K	$260.0K
YoY Change	7.35%	-10.91%	7640.19%
% of Operating Profit	-13.84%	13.94%	5.46%
Other Income/Expense, Net	$0.00	-$230.6K	-$260.9K
YoY Change	-100.0%	-11.62%	4470.34%
Pretax Income	$1.431M	$1.431M	$4.499M
YoY Change	-68.19%	-68.19%	6.49%
Income Tax	$298.6K	$298.6K	$814.5K
% Of Pretax Income	20.86%	20.86%	18.1%
Net Earnings	$1.139M	$1.133M	$3.685M
YoY Change	-69.08%	-69.26%	3.25%
Net Earnings / Revenue	0.26%	0.26%	0.8%
Basic Earnings Per Share		$0.05	$0.17
Diluted Earnings Per Share	$0.05	$0.05	$0.17
COMMON SHARES
Basic Shares Outstanding	25.00M shares	25.00M shares	21.25M shares
Diluted Shares Outstanding		25.00M shares	21.25M shares

Balance Sheet

Concept	2023 Q4	2023	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.403M	$7.403M	$5.033M
YoY Change	47.09%	47.09%	65.81%
Cash & Equivalents	$7.403M
Short-Term Investments
Other Short-Term Assets	$19.35M	$19.35M	$253.8K
YoY Change	7523.12%	7523.12%	-93.85%
Inventory
Prepaid Expenses	$1.686M
Receivables	$25.13M	$25.13M	$18.45M
Other Receivables	$252.2K	$252.2K	$0.00
Total Short-Term Assets	$52.13M	$52.13M	$23.73M
YoY Change	119.64%	119.64%	-11.16%
LONG-TERM ASSETS
Property, Plant & Equipment	$996.5K	$1.335M	$735.7K
YoY Change	152.86%	81.45%	164.98%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00	$0.00	$1.128M
YoY Change	-100.0%	-100.0%
Total Long-Term Assets	$1.335M	$1.335M	$1.864M
YoY Change	-28.39%	-28.39%	571.41%
TOTAL ASSETS
Total Short-Term Assets	$52.13M	$52.13M	$23.73M
Total Long-Term Assets	$1.335M	$1.335M	$1.864M
Total Assets	$53.46M	$53.46M	$25.60M
YoY Change	108.86%	108.86%	-5.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$27.45M	$27.45M	$12.65M
YoY Change	116.98%	116.98%	-30.85%
Accrued Expenses	$521.6K	$521.6K	$249.8K
YoY Change	108.8%	108.8%	107.84%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$27.97M	$27.97M	$13.26M
YoY Change	111.04%	111.04%	-28.41%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$194.4K	$194.4K	$229.1K
YoY Change	-15.15%	-15.15%	361.3%
Total Long-Term Liabilities	$194.4K	$194.4K	$229.1K
YoY Change	-15.15%	-15.15%	361.3%
TOTAL LIABILITIES
Total Short-Term Liabilities	$27.97M	$27.97M	$13.26M
Total Long-Term Liabilities	$194.4K	$194.4K	$229.1K
Total Liabilities	$28.17M	$28.16M	$13.48M
YoY Change	108.89%	108.84%	-27.37%
SHAREHOLDERS EQUITY
Retained Earnings	$12.76M
YoY Change	9.8%
Common Stock	$2.500K
YoY Change	17.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$25.30M	$25.30M	$12.11M
YoY Change
Total Liabilities & Shareholders Equity	$53.46M	$53.46M	$25.60M
YoY Change	108.86%	108.86%	-5.17%

Cashflow Statement

Concept	2023 Q4	2023	2022
OPERATING ACTIVITIES
Net Income	$1.139M	$1.133M	$3.685M
YoY Change	-69.08%	-69.26%	3.25%
Depreciation, Depletion And Amortization	$90.83K	$142.9K	$94.87K
YoY Change	98.32%	50.62%	-22.72%
Cash From Operating Activities	-$2.793M	-$10.03M	$3.499M
YoY Change	-201.93%	-386.72%	-239.6%
INVESTING ACTIVITIES
Capital Expenditures	$233.9K	$773.9K	$373.1K
YoY Change	-35.96%	107.41%	1848.06%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$233.9K	-$773.9K	-$373.1K
YoY Change	-35.96%	107.41%	1848.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-3.280K	$13.18M	-$1.128M
YoY Change	-99.82%	-1267.68%
NET CHANGE
Cash From Operating Activities	-2.793M	-$10.03M	$3.499M
Cash From Investing Activities	-233.9K	-$773.9K	-$373.1K
Cash From Financing Activities	-3.280K	$13.18M	-$1.128M
Net Change In Cash	-3.030M	$2.370M	$1.998M
YoY Change	-675.37%	18.64%	-179.09%
FREE CASH FLOW
Cash From Operating Activities	-$2.793M	-$10.03M	$3.499M
Capital Expenditures	$233.9K	$773.9K	$373.1K
Free Cash Flow	-$3.027M	-$10.81M	$3.126M
YoY Change	-227.45%	-445.7%	-223.77%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001914805
CY2022Q4	us-gaap	Derivative Assets Current DerivativeAssetsCurrent		usd
CY2022Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable		usd
CY2023Q4	us-gaap	Deferred Costs DeferredCosts		usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent		usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest		usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2023	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease		usd
CY2023	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent		usd
CY2023	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities		usd
CY2022	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity		usd
CY2023	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt		usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome		usd
CY2023	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	0	usd
CY2022	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	0	usd
CY2023	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability		usd
CY2022	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability		usd
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41657
CY2023	dei	Entity Registrant Name EntityRegistrantName	CBL INTERNATIONAL LIMITED
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	Level 23-2 Permata Sapura
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Kuala Lumpur City Centre
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	50088
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Kuala Lumpur
CY2023	dei	Entity Address Country EntityAddressCountry	MY
CY2023	dei	Security12b Title Security12bTitle	Ordinary Shares, par value $0.0001 per share
CY2023	dei	Trading Symbol TradingSymbol	BANL
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21250000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21250000	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	2500	usd
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	25000000	shares
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Auditor Name AuditorName	MRI Moores Rowland LLP
CY2023	dei	Auditor Firm AuditorFirmId	6955
CY2023	dei	Auditor Location AuditorLocation	Singapore
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7402890	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5032890	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	25125851	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	18446176	usd
CY2023Q4	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	28776	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	19317189	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	253779	usd
CY2023Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	252209	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	52126915	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	23732845	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	996512	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	394090	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	338481	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	341625	usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts	1128453	usd
CY2023Q4	us-gaap	Assets Assets	53461908	usd
CY2022Q4	us-gaap	Assets Assets	25597013	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	27452815	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	12652514	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	244096	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	343813	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	125701	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	109346	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	177761	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	124095	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	27974389	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13255752	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	194373	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	229076	usd
CY2023Q4	us-gaap	Liabilities Liabilities	28168762	usd
CY2022Q4	us-gaap	Liabilities Liabilities	13484828	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	25000000	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2125	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	12536087	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	488198	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	12761088	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	11621862	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	25299675	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	12112185	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-6529	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	53461908	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25597013	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	435897718	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	462906257	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	428686593	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	453781238	usd
CY2023	us-gaap	Gross Profit GrossProfit	7211125	usd
CY2022	us-gaap	Gross Profit GrossProfit	9125019	usd
CY2023	us-gaap	Selling Expense SellingExpense	1242157	usd
CY2022	us-gaap	Selling Expense SellingExpense	1212108	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4307141	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3152568	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	5549298	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	4364676	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	1661827	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	4760343	usd
CY2023	us-gaap	Interest Expense InterestExpense	231633	usd
CY2022	us-gaap	Interest Expense InterestExpense	259993	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1674	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	45767	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	613	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	48399	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1750	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-230572	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-260875	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1431255	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4499468	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	298605	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	814468	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1132650	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	3685000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1132650	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3685000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	1139226	usd
CY2022	us-gaap	Profit Loss ProfitLoss	3685000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	6576	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1132650	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	3685000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.045
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.045
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.171
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.171
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25000000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25000000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21250000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21250000	shares
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8427185	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	3685000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	12112185	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	12112185	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	12048264	usd
CY2023	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	47	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1132650	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	25293146	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	25293146	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1132650	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	3685000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	170826	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	88175	usd
CY2023	us-gaap	Depreciation Depreciation	142888	usd
CY2022	us-gaap	Depreciation Depreciation	94865	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	613	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	48399	usd
CY2022	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	1750	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	138122	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-109346	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6679675	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	402941	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	19042364	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-3580806	usd
CY2022	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-1509988	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	14779300	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-5644677	usd
CY2023	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	218115	usd
CY2022	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	78242	usd
CY2022	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	291860	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-120781	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-83859	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-496305	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	145679	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10032854	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3499133	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	773863	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	373111	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-773863	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-373111	usd
CY2023	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	13176717	usd
CY2022	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	-1128453	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13176717	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1128453	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2370000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1997569	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5032890	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3035321	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7402890	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5032890	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	302486	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	261703	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	794910	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	688790	usd
CY2023	BANL	Operating Lease Rightofuse Asset And Lease Liabilities OperatingLeaseRightofuseAssetAndLeaseLiabilities	496230	usd
CY2022	BANL	Operating Lease Rightofuse Asset And Lease Liabilities OperatingLeaseRightofuseAssetAndLeaseLiabilities	370439	usd
CY2023	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	3750000	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	2500	usd
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	25000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25000000	shares
CY2023	dei	Parent Entity Legal Name ParentEntityLegalName	CBL International Limited
CY2023	us-gaap	Subsidiary Of Limited Liability Company Or Limited Partnership State SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipState	Cayman Islands
CY2023	us-gaap	Subsidiary Of Limited Liability Company Or Limited Partnership Business Purpose SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipBusinessPurpose	Ultimate holding Company
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_zmXJJbI9995h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>B. <span id="xdx_867_zGQfc0Bt66o3">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with U.S. GAAP requires the Company to make certain estimates and assumptions that affect the amounts reported and disclosed in the consolidated financial statements and related notes. The most significant estimates and judgments include the allowance for doubtful accounts, useful life of property, plant and equipment, income taxes and uncertain tax positions. Actual amounts could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zOYOq9DGpnA5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>D. <span id="xdx_863_zc1Sm5hWRcx9">Certain Risks and Concentration</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. A depositor has up to RMB <span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_uCNY_c20231231__srt--TitleOfIndividualAxis__custom--DepositorMember_zpk1j434gGVg" title="Insured amount">500,000</span> (approximately $<span id="xdx_90E_eus-gaap--CashFDICInsuredAmount_iI_c20231231__srt--TitleOfIndividualAxis__custom--DepositorMember_znBoqGLf5scf" title="Insured amount">72,000</span>) insured by the People’s Bank of China Financial Stability Bureau (“FSD”). As of December 31, 2023, the Company’s cash was below RMB <span id="xdx_90A_eus-gaap--CashFDICInsuredAmount_iI_uCNY_c20231231_zRsiw3jbXrpl" title="Insured amount">500,000</span> and so it that fully insured. The Hong Kong Deposit Protection Board insures up to a limit of HK$<span id="xdx_902_eus-gaap--CashFDICInsuredAmount_iI_uHKD_c20231231_zWFxhqD4NpB4" title="Insured amount">500,000</span> (approximately $<span id="xdx_905_eus-gaap--CashFDICInsuredAmount_iI_c20231231_zGW4AKsAwSHl" title="Insured amount">64,000</span>) if the bank with which an individual/a company hold its eligible deposit fails. As of December 31, 2023, approximately $<span id="xdx_901_eus-gaap--CashUninsuredAmount_iI_c20231231_zHKH0yuXHjT1" title="Cash uninsured amount">4,709,000</span> was not insured by the Hong Kong Deposit Protection Board. While management believes that these financial institutions and platform fund holders are of high credit quality, it continually monitors their credit worthiness.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Major Customers and Suppliers</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zZJJ6S1SO9g7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the years ended December 31, 2023 and 2022, three of the Company’s customers accounted for more than 10% of revenue:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span id="xdx_8BC_zeTLX0hXcfJ6" style="display: none">Schedules of Concentration of Risk Percentage</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230101__20231231_zOwwtmqxyyG3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20220101__20221231_zrcCpPqSuU43" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Revenue:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_znAW1x5D3aeg" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left">Customer A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">38.6</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">39.7</td><td style="width: 1%; text-align: left">%</td></tr> <tr id="xdx_405_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zzvKLTb6DFek" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Customer B</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">11.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">11.3</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31, 2023 and 2022, the following customers accounted for more than 10% of the Company’s accounts receivable:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230101__20231231_zl8JDqyqyM39" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20220101__20221231_zH53IFJcbtyf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accounts receivable:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zirfJr5Y6VE1" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left">Customer A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">7.9</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">22.4</td><td style="width: 1%; text-align: left">%</td></tr> <tr id="xdx_407_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zY0tIhaZGzki" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13.8</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.0</td><td style="text-align: left">%</td></tr> <tr id="xdx_40C_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerIMember_z5RDnV6gmb7c" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer I</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14.7</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0625">-</span></td><td style="text-align: left">%</td></tr> <tr id="xdx_40C_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerJMember_zau8Hqr1O2d6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Customer J</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">15.6</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0628">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The top three suppliers that individually represented greater than 10% of total cost of revenue of the Company for the years ended December 31, 2023 and 2022 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230101__20231231_zNRCwUEPlbGf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20220101__20221231_zJoIhCikASvf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Cost of revenue:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierAMember_zf03fXLqGQTh" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left">Supplier A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">15.7</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">30.7</td><td style="width: 1%; text-align: left">%</td></tr> <tr id="xdx_403_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierBMember_z3PU8BMDyQOc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Supplier B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.7</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10.4</td><td style="text-align: left">%</td></tr> <tr id="xdx_407_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierCMember_zYJtjKdkBZnh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Supplier C</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">13.4</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">17.4</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31, 2023 and 2022, the following suppliers accounted for more than 10% of the Company’s accounts payable:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230101__20231231_zpYT8pnCXc0d" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20220101__20221231_zmxZZjDyEzf7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accounts payable:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierBMember_z03puKibRZy9" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left">Supplier B</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">1.7</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">13.1</td><td style="width: 1%; text-align: left">%</td></tr> <tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierCMember_zqa7mZK3Sl07" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Supplier C</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18.7</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">26.3</td><td style="text-align: left">%</td></tr> <tr id="xdx_402_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierEMember_zNSO4orZBtCf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Supplier E</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18.5</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7.9</td><td style="text-align: left">%</td></tr> <tr id="xdx_405_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierFMember_zYAGANLaHYG4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Supplier F</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14.1</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0649">-</span></td><td style="text-align: left">%</td></tr> <tr id="xdx_40E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierIMember_zgJFlriusqOh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Supplier I</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0651">-</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21.5</td><td style="text-align: left">%</td></tr> <tr id="xdx_40A_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierJMember_zy0r520JRAWd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Supplier J</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0654">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">12.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> <tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierJMember_z9bNgFtLkhN3" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Concentration risk percentage</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0657">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">12.0</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p id="xdx_8A1_zGVx5h1Gi241" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	500000	cny
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	500000	hkd
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	64000	usd
CY2023Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	4709000	usd
CY2023Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	1800000	usd
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	1100000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	25125851	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	18446176	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023	us-gaap	Accounts Receivable Sale AccountsReceivableSale	1684268	usd
CY2022	us-gaap	Accounts Receivable Sale AccountsReceivableSale	5168297	usd
CY2023	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	1626345	usd
CY2022	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	4134637	usd
CY2023	BANL	Proceeds From Bank Debt Upon Settlements ProceedsFromBankDebtUponSettlements	57922	usd
CY2022	BANL	Proceeds From Bank Debt Upon Settlements ProceedsFromBankDebtUponSettlements	1033659	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1686014	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	167677	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	17631175	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	86102	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	19317189	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	253779	usd
CY2023Q4	us-gaap	Deposits Deposits	17549000	usd
CY2023	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	15000	usd
CY2022	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	13000	usd
CY2023	BANL	Factoring Facility FactoringFacility	15200000	usd
CY2022	BANL	Factoring Facility FactoringFacility	13600000	usd
CY2023	us-gaap	Accounts Receivable Purchase AccountsReceivablePurchase	1600000	usd
CY2022	us-gaap	Accounts Receivable Purchase AccountsReceivablePurchase	4100000	usd
CY2023Q4	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	13600000	usd
CY2022Q4	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	9500000	usd
CY2023	us-gaap	Interest Income Other InterestIncomeOther	70853	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	1710	usd
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	12379	usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	4958	usd
CY2023	us-gaap	Interest Expense InterestExpense	231633	usd
CY2022	us-gaap	Interest Expense InterestExpense	259993	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000000	hkd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	298605	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	814468	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	298605	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	814468	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1431255	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4499468	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.165	pure
CY2023	us-gaap	Income Tax Reconciliation Tax Settlements Domestic IncomeTaxReconciliationTaxSettlementsDomestic	236157	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Settlements Domestic IncomeTaxReconciliationTaxSettlementsDomestic	742412	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-21290	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-21290	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	2102	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	1322	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	110412	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	37595	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	22790	usd
CY2023	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-5986	usd
CY2022	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	54429	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	298605	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	814468	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	435897718	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	462906257	usd
CY2023	BANL	Finance Lease And Operating Lease Costs FinanceLeaseAndOperatingLeaseCosts	155267	usd
CY2022	BANL	Finance Lease And Operating Lease Costs FinanceLeaseAndOperatingLeaseCosts	99823	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	11217	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	19892	usd
CY2023	us-gaap	Lease Cost LeaseCost	166484	usd
CY2022	us-gaap	Lease Cost LeaseCost	119715	usd
CY2023	us-gaap	Payments For Rent PaymentsForRent	140000	usd
CY2022	BANL	Termination Of Lease TerminationOfLease	55000	usd
CY2022	us-gaap	Payments For Rent PaymentsForRent	370000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	189499	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	199401	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	388900	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	16766	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	372134	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	338481	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	341625	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	177761	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	124095	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	194373	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	229076	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y9M18D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.039	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.032	pure
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	120781	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	83859	usd

Files In Submission

Name	View Source	Status
0001493152-24-015142-index-headers.html	Edgar Link	pending
0001493152-24-015142-index.html	Edgar Link	pending
0001493152-24-015142.txt	Edgar Link	pending
0001493152-24-015142-xbrl.zip	Edgar Link	pending
banl-20231231.xsd	Edgar Link	pending
ex11-2.htm	Edgar Link	pending
ex11-2_001.jpg	Edgar Link	pending
ex11-2_002.jpg	Edgar Link	pending
ex11-2_003.jpg	Edgar Link	pending
banl-20231231_cal.xml	Edgar Link	unprocessable
banl-20231231_def.xml	Edgar Link	unprocessable
banl-20231231_lab.xml	Edgar Link	unprocessable
banl-20231231_pre.xml	Edgar Link	unprocessable
ex11-2_004.jpg	Edgar Link	pending
ex12-1.htm	Edgar Link	pending
ex12-2.htm	Edgar Link	pending
ex13-1.htm	Edgar Link	pending
ex13-2.htm	Edgar Link	pending
ex2-2.htm	Edgar Link	pending
ex8-1.htm	Edgar Link	pending
ex97.htm	Edgar Link	pending
ex97_001.jpg	Edgar Link	pending
ex97_002.jpg	Edgar Link	pending
ex97_003.jpg	Edgar Link	pending
ex97_004.jpg	Edgar Link	pending
ex97_005.jpg	Edgar Link	pending
ex97_006.jpg	Edgar Link	pending
ex97_007.jpg	Edgar Link	pending
ex97_008.jpg	Edgar Link	pending
ex97_009.jpg	Edgar Link	pending
ex97_010.jpg	Edgar Link	pending
ex97_011.jpg	Edgar Link	pending
ex97_012.jpg	Edgar Link	pending
ex97_013.jpg	Edgar Link	pending
ex97_014.jpg	Edgar Link	pending
ex97_015.jpg	Edgar Link	pending
ex99.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form20-f.htm	Edgar Link	pending
form20-f_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
form20-f_htm.xml	Edgar Link	completed
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BANL
CBL International Ltd Stock $banl

2023 Q4 Form 20-F Financial Statement

#000149315224015142 Filed on April 18, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BANL CBL International Ltd Stock $banl

2023 Q4 Form 20-F Financial Statement

#000149315224015142 Filed on April 18, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BANL
CBL International Ltd Stock $banl